CATABASIS PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about news in CATABASIS PHARMACEUTICALS INC.

The service is free and you can unsubscribe at any time.

General | People (42) | Filings (130) | Investment rounds (8) | Annual reports (2) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001454789

CATABASIS PHARMACEUTICALS INC is a publicly traded company

Trading symbol: CATB

CATABASIS PHARMACEUTICALS INC is on the market more than 5 years.

News

2017-06-23

Trial of Edasalonexent (CAT-1004) at the 2017 PPMD Annual Connect Conference
Business Wire (press release)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present data from Part A and Part B of the MoveDMD trial of edasalonexent (CAT-1004) in ...

2017-06-22

Catabasis Pharmaceuticals' (CATB) Outperform Rating Reaffirmed at Wedbush
The Cerbat Gem
Catabasis Pharmaceuticals, Inc. logo Wedbush reissued their outperform rating on shares of Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) in a research note issued to investors on Wednesday. They currently have a $4.00 price target on the ...
Catabasis Pharmaceuticals, Inc. (CATB) Cut to “Hold” at Zacks Investment Research - Stock Observer
Catabasis Pharmaceuticals (CATB) Getting Positive News Coverage, Accern Reports - Sports Perspectives

2017-06-22

Analyst Observation On 2 Stocks: Catabasis Pharmaceuticals, Inc. (CATB ...
Post Analyst
The company's consensus rating on Reuter's scale remained unchanged from 1.33 to 1.33 during a month. Analysts set a 12-month price target of $21.1 a share.

2017-06-21

Pre-Market Technical Recap on Biotech Stocks -- Array BioPharma, Catabasis ...
PR Newswire (press release)
DailyStockTracker.com has initiated coverage on the following Biotech stocks: Array BioPharma Inc. (NASDAQ: ARRY), Catabasis Pharmaceuticals Inc. (NASDAQ: CATB), Cerulean Pharma Inc. (NASDAQ: CERU), and Immunomedics Inc. (NASDAQ: IMMU).

2017-06-20

Catabasis Pharmaceuticals (CATB) Earns Daily News Impact Rating of 0.34
The Cerbat Gem
Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $9.00 price target (down from $11.00) on shares of Catabasis Pharmaceuticals in a report on Monday, May 15th. Finally, Zacks Investment Research raised Catabasis Pharmaceuticals ...
The Catabasis Pharmaceuticals, Inc. (CATB) Rating Reiterated by Wedbush - BangaloreWeekly
-$0.41 EPS Expected for Catabasis Pharmaceuticals, Inc. (CATB) This Quarter - Transcript Daily

2017-06-18

Catabasis Pharmaceuticals, Inc. (CATB) Receives $6.25 Average Price Target ...
The Cerbat Gem
Catabasis Pharmaceuticals logo Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) has earned an average rating of “Hold” from the six brokerages that are presently covering the company, Marketbeat Ratings reports.
Wedbush Reiterates Ourperform Rating for Catabasis Pharmaceuticals, Inc. (CATB) - Sports Perspectives
Catabasis Pharmaceuticals, Inc. (CATB) Receives $6.25 Average PT from Brokerages - Markets Daily

2017-06-16

The Catabasis Pharmaceuticals, Inc. (CATB) Given Consensus Recommendation of ...
BangaloreWeekly
CATB has been the subject of several research reports. Zacks Investment Research cut Catabasis Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Friday, May 19th.
Catabasis Pharmaceuticals (CATB) Receiving Favorable News Coverage, AlphaOne ... - Sports Perspectives

CATABASIS PHARMACEUTICALS INC address

ONE KENDALL SQUARE
BLDG. 1400E, SUITE B14202
CAMBRIDGE
02139

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

January 2009

Latest known filing

June 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

CATABASIS PHARMACEUTICALS INC has 130 filings. View CATABASIS PHARMACEUTICALS INC filings.

Annual Reports

Quarterly Reports

Latest company events

Investment Rounds

CATABASIS PHARMACEUTICALS INC recieved 8 investments.

People

We have found 42 people related to CATABASIS PHARMACEUTICALS INC.